Francis Knuettel II - Insider Non-Derivative Transactions at Chromocell Therapeutics Corp (CHRO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 13, 2024, Francis Knuettel II's relationship to Chromocell Therapeutics Corp (CHRO) is Officer (CEO, Pres., CFO, Treas & Secty), and currently has 547,710 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CHRO insiders.
Data Source: SEC.
Francis Knuettel II - Insider Non-Derivative Transactions of CHRO Common Stock
Francis Knuettel II - Insider Non-Derivative Transactions at CHRO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 14, 2024 | P -- (Common Stock) | 3500 | 0.97 | 547710 |
| Sep 13, 2024 | P -- (Common Stock) | 1700 | 0.97 | 544210 |
| Sep 12, 2024 | P -- (Common Stock) | 5500 | 0.94 | 542510 |
| Sep 11, 2024 | P -- (Common Stock) | 6500 | 0.89 | 537010 |
| Jun 29, 2024 | G -- (Common Stock) | 15000 | 0 | 515510 |
| Jun 29, 2024 | G -- (Common Stock) | 5000 | 0 | 530510 |